Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia

BACKGROUND: Most hypomethylating agent (HMA) responders with myelodysplastic syndrome (MDS) eventually need allogeneic stem cell transplantation (SCT) because they often acquire resistance to HMAs within two years of treatment. Considering the nature of MDS and the poor outcomes of SCT when performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Sang Kyun, Moon, Joon Ho, Lee, Yoo Jin, Park, Sung Woo, Kim, Ji Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828528/
https://www.ncbi.nlm.nih.gov/pubmed/27104191
http://dx.doi.org/10.5045/br.2016.51.1.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828528/
https://www.ncbi.nlm.nih.gov/pubmed/27104191
http://dx.doi.org/10.5045/br.2016.51.1.44

Ejemplares similares